Chiropractors in Fairbury, NE Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Dr. Tara Whipple, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 414 E St, Fairbury, NE 68352 Phone: 402-729-5181

Jeffrey Alan Botz, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 925 14th St, Fairbury, NE 68352 Phone: 402-729-2213    Fax: 866-500-2179

Tatro Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 425 D St, Fairbury, NE 68352 Phone: 402-729-5181    Fax: 402-729-5182

Dr. Thayne A. Tatro, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 425 D St, Fairbury, NE 68352 Phone: 402-729-5181    Fax: 402-729-5182

News Archive

Upcoming web conference focuses on Next Generation Ultrasound Market in Europe

Exposure to radiation from imaging equipment is constantly subjected to scrutiny from regulatory authorities. Ultrasound poses no radiation threat and is constantly further developed to accentuate primary and secondary diagnosis. The next wave in ultrasound technology will witness advancements in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis.

Synteract joins Medidata's ASPire to Win channel partner program

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Synteract has joined Medidata's ASPire to Win® channel partner program. A full-service contract research organization (CRO) with an increasing global presence and extensive experience working with emerging biotech, pharmaceutical and medical device sponsors, Synteract will offer services around Medidata Rave®, the market-leading electronic data capture (EDC) and clinical data management (CDM) solution.

University of Warwick researchers discover molecular phenomenon using solid-state NMR facility

Cutting edge technology has shown a molecule self-assembling into different forms when passing between solution state to solid state, and back again - a curious phenomenon in science - says research by the University of Warwick.

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

Astellas, Ambit announce results from quizartinib Phase 2 study on acute myeloid leukemia

Astellas Pharma Inc. and Ambit Biosciences Corporation announced today that the results from a completed Phase 2 study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral monotherapy treatment regimen in patients with relapsed or refractory acute myeloid leukemia (AML) were presented at the 54th Annual Meeting of the American Society of Hematology (ASH).

Read more Medical News

› Verified 8 days ago